# Meeting of the Advisory Board on Radiation and Worker Health, Subcommittee for Procedure Reviews, National Institute for Occupational Safety and Health
**AGENCY:**
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
**ACTION:**
Notice of meeting.
**SUMMARY:**
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the Subcommittee on Procedures Reviews (SPR) of the Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board). This meeting is open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. The public is also welcome to listen to the meeting by joining the audio conference (information below). The audio conference line has 150 ports for callers.
**DATES:**
The meeting will be held on January 28, 2026, from 11 a.m. to 4:30 p.m., EST.
Written comments must be received on or before January 21, 2026.
**ADDRESSES:**
You may submit comments by mail to: Rashaun Roberts, Ph.D., Designated Federal Officer, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1090 Tusculum Avenue, Mailstop C-24, Cincinnati, Ohio 45226. Email: *[email protected].*
Written comments received in advance of the meeting will be included in the official record of the meeting.
*Meeting Information:* Audio Conference Call via FTS Conferencing. The USA toll-free dial-in number is 1-866-659-0537; the passcode is 9933701.
**FOR FURTHER INFORMATION CONTACT:**
Rashaun Roberts, Ph.D., Designated Federal Officer, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1090 Tusculum Avenue, Mailstop C-24, Cincinnati, Ohio 45226, Telephone: (513) 533-6800, Email: *[email protected].*
**SUPPLEMENTARY INFORMATION:**
*Background:* The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines, which have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC.
The charter was issued on August 3, 2001, renewed at appropriate intervals, and rechartered under Executive Order 14109 (September 29, 2023) on March 22, 2024. Unless continued by the President, the Advisory Board will terminate on September 30, 2027, consistent with Executive Order 14354 of September 29, 2025.
*Purpose:* The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The ABRWH Subcommittee on Procedure Reviews (SPR) is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU).
*Matters to be Considered:* The agenda will include discussions on the following:
1. Administrative items, including: a. SPR-approved documents for next Full Board meeting, b. discussion of professional judgement assessment of six PER-017 case reviews. c. list of documents awaiting NIOSH responses, including: i. Discussion of SPR priorities, and 2. Carry-over items from March 14, 2024, SPR Meeting including a. ORAUT-OTIB-0036, rev. 00 “Internal Dosimetry Coworker Data for Portsmouth Gaseous Diffusion Plant” b. ORAUT-OTIB-0040, rev. 00 PC-1 “External Coworker Dosimetry Data for the Portsmouth Gaseous Diffusion Plant.”; 3. NIOSH responses to Board questions and SC&A review including: a. ORAUT-OTIB-0052, rev. 00 “Parameters to Consider When Processing Claims for Construction Trade Workers,” b. ORAUT-RPRT-0071, rev. 00 “External Dose Coworker Methodology,” and c. “Internal Dosimetry Coworker Data for Portsmouth Gaseous Diffusion Plant”; 4. SC&A issued reviews: a. DCAS-PER-075, rev. 0 “Battelle Memorial Institute TBD revision,” b. DCAS-PER-040, rev. 0 “Mallinckrodt TBD Revisions,” c. DCAS-PER-051, rev. 0, ST4 “Weldon Spring Plant,” d. DCAS-PER-083, rev. 0, ST4 “Weldon Spring Plant,” e. DCAS-PER-079 rev. 0 “Pinellas TBD Revision,” f. DCAS-PER-034 rev. 0 “Harshaw Chemical Company TBD Revision,” g. DCAS-PER-036, rev. 0 “Blockson TBD Revision,” h. DCAS-PER-039, rev. 0 “Baker Perkins TBD Revision,” 5. Newly-Issued Guidance and Supplemental Topics. Agenda items are subject to change as priorities dictate. For additional information, please contact Toll Free 1(800) 232-4636.
The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.